Alicia Batts is a Partner in the Antitrust Group and the firm’s Litigation Department, resident in the Washington, D.C. office. An experienced antitrust lawyer, she litigates cases before federal courts throughout the United States and represents clients before federal and state agencies. Her practice spans the full range of antitrust and unfair competition-related litigation, including class actions, competitor suits, dealer/distributor termination suits, price discrimination cases, criminal price-fixing investigations, and merger injunctions.
Alicia has extensive experience providing antitrust counseling for companies in a range of industries, including automotive, aeronautics, pharmaceutical, financial and energy. In addition to antitrust litigation, she regularly represents clients before the antitrust enforcement agencies.
Prior to joining the firm, Alicia worked as an Attorney Advisor to Federal Trade Commissioner Mozelle Thompson, for whom she reviewed antitrust actions before the FTC and made recommendations on enforcement and policy matters before the Federal Antitrust Agency.
In 2011, Alicia advised Grifols, S.A., on the antitrust aspects of its $4.1 billion acquisition of Talecris Biotherapeutics Holdings Corp. The Proskauer team was able to negotiate a consent agreement allowing Grifols to purchase Talecris after it divested certain assets. For her work on Grifols, Alicia was featured in Global Competition Review, Law360 and The Deal. Currently, the transaction is a finalist for Merger Control Matter of the Year Award – Americas by Global Competition Review.
A regular panelist at antitrust conferences and a former Vice-Chair of the ABA Antitrust Section. Alicia is currently the Vice Chair of the Emerging Issues in Healthcare Law Conference Planning Committee. She also is a member of the board of directors of the Appleseed Foundation and Co-chair of its nomination committee.
read more »